PATENT CLAIM ANALYSIS

Application Number: 16168002
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["435", "194000"]

Abstract:
The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

Claim (Index 16):
The method of  claim 12 , wherein said R2 reverse transcription enzyme has at least 90% identity to SEQ ID NO: 53 and contains at least one substitution modification relative to SEQ ID NO: 52.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15410211', '12095409', '14414104', '10362703', '10178673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6488345531351997
- 35 USC 102 Novelty (BERT): 0.5149710712476246
- Combined Prediction Score: 0.6354482049464423
- Mean Citation Score: 289.7231060000001
- Max Citation Score: 300.6831
- Similarity Product: 200.6169737899661

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test